Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · IEX Real-Time Price · USD
1.630
0.00 (0.00%)
May 1, 2024, 4:00 PM EDT - Market closed
Carisma Therapeutics Revenue
In the year 2023, Carisma Therapeutics had annual revenue of $14.92M with 51.71% growth. Revenue in the quarter ending December 31, 2023 was $4.29M with 14.96% year-over-year growth.
Revenue (ttm)
$14.92M
Revenue Growth
+51.71%
P/S Ratio
4.54
Revenue / Employee
$139,430
Employees
107
Market Cap
67.71M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.92M | 5.09M | 51.71% |
Dec 31, 2022 | 9.83M | -16.71M | -62.95% |
Dec 31, 2021 | 26.54M | 15.31M | 136.24% |
Dec 31, 2020 | 11.24M | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 425.00K | -29.56M | -98.58% |
Dec 31, 2016 | 29.98M | 28.99M | 2,928.38% |
Dec 31, 2015 | 990.00K | -1.25M | -55.86% |
Dec 31, 2014 | 2.24M | 909.00K | 68.14% |
Dec 31, 2013 | 1.33M | - | - |
Dec 31, 2012 | 0 | - | - |
Dec 31, 2011 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SCYNEXIS | 140.14M |
Personalis | 73.48M |
Alpha Teknova | 36.68M |
Silver Spike Investment | 7.76M |
Cue Biopharma | 5.49M |
VolitionRx | 775.30K |
CARM News
- 9 days ago - Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - PRNewsWire
- 4 weeks ago - Carisma Therapeutics to Present at Upcoming Conferences - PRNewsWire
- 4 weeks ago - Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire
- 4 weeks ago - Carisma Therapeutics Announces Changes to its Board of Directors - PRNewsWire
- 5 weeks ago - Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting - PRNewsWire
- 2 months ago - Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference - PRNewsWire
- 4 months ago - Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 4 months ago - First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration - PRNewsWire